GSTP1 and Sepsis: In conclusion, the in vivo work on Gstp−/− mice fully demonstrates that GSTP acts as a negative regulator in sepsis pathophysiology, and recombinant GSTP protein treatment to mice may significantly improve survival in mouse CLP sepsis model.